Abstract
The chronopharmacokinetics of diltiazem were investigated after administration of a 60mg oral dose (immediate release capsule) at 4 different times over 24 hours (0600, 1200, 1800 and 2400h) to 8 healthy human volunteers in a randomised crossover study with a washout period of 1 week. Serum samples were analysed for unchanged diltiazem using high performance liquid chromatography. Pharmacokinetic parameters were calculated using model independent methods. A significant decrease in the Cmax (F = 6.52, p < 0.002) and AUC0-α (F = 3.26, p < 0.05) as well as an increase in the oral clearance (F = 3.62, p < 0.05) and apparent volume of distribution (F = 5.85, p < 0.01) were observed following administration at 0600h. Following the 2400h dose administration, the elimination half-life was significantly decreased as compared with that at the other dose times (F = 4.11, p < 0.025). These variations appear to be a result of time-dependent changes in the metabolism of diltiazem.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
